Target-Centered Drug Repurposing Predictions of Human 'ACE2' and 'TMPRSS2' Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment
Yoonjung Choi, Bonggun Shin, Keunsoo Kang, Sungsoo Park, Bo Ram Beck
Predicting FOXM1-Mediated Gene Regulation through the Analysis of Genome-Wide FOXM1 Binding Sites in MCF-7, K562, SK-N-SH, GM12878 and ECC-1 Cell Lines
Community Assessment of the Predictability of Cancer Protein and Phosphoprotein Levels from Genomics and Transcriptomics
Mi Yang, Francesca Petralia, Zhi Li, Hongyang Li, Weiping Ma, Xiaoyu Song, Sunkyu Kim, Heewon Lee, Han Yu, Bora Lee, Seohui Bae, Eunji Heo, Jan Kaczmarczyk, Piotr Stępniak, Michał Warchoł, Thomas Yu, Anna P. Calinawan, Paul C. Boutros, Samuel H. Payne, Boris Reva, NCI-CPTAC-DREAM Consortium, Emily Boja, Henry Rodriguez, Gustavo Stolovitzky, Yuanfang Guan, Jaewoo Kang, Pei Wang, David Fenyö, Julio Saez-Rodriguez
Molecular optimization of phase III trial failed anticancer drugs using target affinity and toxicity-centered multiple properties reinforcement learning
Sungsoo Park, Yoon Ho Ko, Bora Lee, Bonggun Shin and Bo Ram Beck
Computational and Structural Biotechnology Journal, 2020
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Bo Ram Beck, Bong gun Shin, Yoonjung Choi, Sungsoo Park, Keunsoo Kang
DeepBTS: Prediction of Recurrence-free Survival of Non-small Cell Lung Cancer Using a Time-binned Deep Neural Network
Bora Lee, Sang Hoon Chun, Ji Hyung Hong, In Sook Woo, Seoree Kim, Joon Won Jeong, Jae Jun Kim, Hyun Woo Lee, Sae Jung Na, Kyongmin Sarah Beck, Bomi Gil, Sungsoo Park, Ho Jung An & Yoon Ho Ko
Expression of EEF1A1 Is Associated with Prognosis of Patients with Colon Adenocarcinoma
Eun kyo Joung, Jiyoung Kim,Nara Yoon, Lee-so Maeng, Ji Hoon Kim, Sungsoo Park, Keunsoo Kang, Jeong Seon Kim, Young Ho Ahn,Yoon Ho Ko, Jae Ho Byun, Ji Hyung Hong